The hypothalamus of an adult living with narcolepsy type 1 (NT1) measures smaller than that of a person without the disorder, ...

Transplant weight-loss access, a new dermatomyositis drug, mifepristone safety views, and racial gaps in cataract surgery and ...

The federal government's posture in Texas v Kennedy —a lawsuit over HHS's 2024 update to Section 504 of the Rehabilitation ...

MINT randomized 238 patients to inebilizumab 300 mg IV vs placebo with a protocol-driven taper to prednisone ≤5 mg/day and ...

A large, long-term real-world study found that biologic therapy for psoriasis is linked to a significantly lower risk of ...

Tirzepatide is now approved to lower cardiovascular death, heart attack, or stroke risk in adults with type 2 diabetes.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press. In its article, The ...

FDA approves brepocitinib, the first oral, targeted therapy for adult dermatomyositis, backed by phase 3 VALOR data. For the ...

At a Chicago roundtable, clinicians detailed fragmented obesity and diabetes care, transplant-access barriers, and ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...